The binding of the MM1 antibody to HEK293T cells overexpressing syndecan-1 was around 6.6-fold weaker than that seen with MM cells, suggesting that the heparan sulfate is highly modified in MM cells. The gene discussed is SDC1; the disease is Miyoshi myopathy.